Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Dietary proteins in Ensure Plus refer to the specific blend of high-quality proteins found in this oral nutritional supplement, which typically includes milk protein concentrate, sodium caseinate, and soy protein isolate (Abbott Nutrition, 2024). These proteins are not therapeutic targets in the traditional pharmacological sense, such as receptors or enzymes; instead, they are macronutrients designed to provide the essential amino acids necessary for protein synthesis and the maintenance of lean body mass (StatPearls, 2023). Clinically, these proteins are used to manage patients with malnutrition, cachexia, or those recovering from major surgery and chronic illness where nutritional requirements are elevated (NIH, 2023). By supporting a positive nitrogen balance, they play a critical role in immune function and tissue integrity. From a pharmacological perspective, the intake of these dietary proteins can significantly influence the efficacy of certain medications. For instance, large neutral amino acids derived from these proteins compete with levodopa for transport across the intestinal wall and the blood-brain barrier via the L-type amino acid transporter (LAT1), potentially reducing the drug's effectiveness in Parkinson's disease patients (Journal of Clinical Movement Disorders, 2015). Additionally, the mineral content often associated with these protein sources in nutritional drinks can chelate antibiotics like ciprofloxacin, necessitating careful timing of administration. While generally safe, these proteins pose risks for individuals with specific food allergies or those with advanced renal disease who require protein restriction (National Kidney Foundation, 2023).
Provision of a complete profile of essential and non-essential amino acids to support anabolic processes, promote cellular repair, and maintain lean body mass in catabolic or malnourished states (StatPearls, 2023).
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dietary proteins in Ensure Plus.